TR199902888A3 - Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari. - Google Patents

Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari.

Info

Publication number
TR199902888A3
TR199902888A3 TR1999/02888A TR9902888A TR199902888A3 TR 199902888 A3 TR199902888 A3 TR 199902888A3 TR 1999/02888 A TR1999/02888 A TR 1999/02888A TR 9902888 A TR9902888 A TR 9902888A TR 199902888 A3 TR199902888 A3 TR 199902888A3
Authority
TR
Turkey
Prior art keywords
medicines
preparation
erythromycin derivatives
new erythromycin
new
Prior art date
Application number
TR1999/02888A
Other languages
English (en)
Turkish (tr)
Other versions
TR199902888A2 (xx
Inventor
Denis Alexis
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of TR199902888A2 publication Critical patent/TR199902888A2/xx
Publication of TR199902888A3 publication Critical patent/TR199902888A3/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
TR1999/02888A 1998-11-24 1999-11-24 Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari. TR199902888A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (2)

Publication Number Publication Date
TR199902888A2 TR199902888A2 (xx) 2000-06-21
TR199902888A3 true TR199902888A3 (tr) 2000-06-21

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02888A TR199902888A3 (tr) 1998-11-24 1999-11-24 Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari.

Country Status (24)

Country Link
US (2) US6440941B1 (https=)
EP (1) EP1004592B1 (https=)
JP (1) JP2000159790A (https=)
KR (1) KR100587445B1 (https=)
CN (1) CN1165546C (https=)
AR (1) AR021388A1 (https=)
AT (1) ATE245160T1 (https=)
AU (1) AU772171B2 (https=)
BR (1) BR9905735A (https=)
CA (1) CA2290136C (https=)
DE (1) DE69909577T2 (https=)
DK (1) DK1004592T3 (https=)
ES (1) ES2198867T3 (https=)
FR (1) FR2786188B1 (https=)
HU (1) HUP9904392A3 (https=)
IL (1) IL133101A (https=)
MX (1) MXPA99010813A (https=)
NO (1) NO314729B1 (https=)
PL (1) PL336736A1 (https=)
PT (1) PT1004592E (https=)
RU (1) RU2237672C2 (https=)
TR (1) TR199902888A3 (https=)
TW (1) TWI247747B (https=)
ZA (1) ZA997176B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
CA2359708C (en) 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
HUP0201516A3 (en) 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
WO2009137787A1 (en) * 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Also Published As

Publication number Publication date
CA2290136C (fr) 2010-07-20
FR2786188B1 (fr) 2002-10-31
CN1263101A (zh) 2000-08-16
KR20000057017A (ko) 2000-09-15
CA2290136A1 (fr) 2000-05-24
NO995745L (no) 2000-05-25
HU9904392D0 (en) 2000-01-28
ATE245160T1 (de) 2003-08-15
PL336736A1 (en) 2000-06-05
NO314729B1 (no) 2003-05-12
IL133101A0 (en) 2001-03-19
MXPA99010813A (es) 2005-09-08
DE69909577T2 (de) 2004-06-03
TR199902888A2 (xx) 2000-06-21
RU2237672C2 (ru) 2004-10-10
EP1004592B1 (fr) 2003-07-16
US20030050254A1 (en) 2003-03-13
AU772171B2 (en) 2004-04-08
TWI247747B (en) 2006-01-21
AU5952299A (en) 2000-05-25
FR2786188A1 (fr) 2000-05-26
EP1004592A1 (fr) 2000-05-31
US6664398B2 (en) 2003-12-16
US6440941B1 (en) 2002-08-27
HUP9904392A3 (en) 2001-08-28
HUP9904392A2 (hu) 2000-05-28
AR021388A1 (es) 2002-07-17
JP2000159790A (ja) 2000-06-13
BR9905735A (pt) 2000-08-08
DK1004592T3 (da) 2003-10-27
DE69909577D1 (de) 2003-08-21
KR100587445B1 (ko) 2006-06-08
NO995745D0 (no) 1999-11-23
IL133101A (en) 2007-02-11
PT1004592E (pt) 2003-12-31
CN1165546C (zh) 2004-09-08
ZA997176B (en) 2000-11-20
ES2198867T3 (es) 2004-02-01

Similar Documents

Publication Publication Date Title
TR199902888A3 (tr) Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari.
DE50014425D1 (de) Asymmetrischer, mehrstrahliger radarsensor
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
IS4309A (is) Nýjar erýþrómýsin afleiður, sem og læknislyf sem innihalda þær
ZA200107983B (en) New compounds, their preparation and use.
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
TR199601002A1 (tr) 2-Okzo- ve 2-thio-1, 2-dihidrokinolinil-oksazolidinonlar.
MXPA03000078A (es) Derivados de purina.
TR199600664A2 (tr) 11-(ikameli fenil)-estra-4, 9-dien türevleri.
IS5527A (is) Nýjar erýþrómýsín afleiður
TR199802624A3 (tr) Yeni farmasötik.
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
HUP0104035A3 (en) Novel erythromycin derivatives, preparation method and use as medicines
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
NO20004015D0 (no) Biretningsmessig, fremstillbar, løftegenererende maskestang
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE69906149D1 (de) 4,5-azolo-oxindole
ITBO990671A0 (it) Maniglione antipanico.
TR199900285A3 (tr) Yeni eritromisin türevleri ve bunlari içeren ilaçlar.
IT1304194B1 (it) Acetali, loro preparazioni, loro utilizzazioni.
DE60000826D1 (de) 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
MA26590A1 (fr) Derives de thiazole, leur procede de preparation et leur utilisation.